Adaptive Sensory Technology (AST) is a groundbreaking brand that specializes in precision-based innovation. Founded by a team of experts from Harvard Medical School (HMS) and the Ohio State University (OSU), AST's technology is the result of ten years of intensive research and development. With a strong foundation in experimental psychology and physics, the team at AST understands the importance of meticulous experiments carried out with precision instruments.

AST's main focus is on developing unique computational and statistical frameworks for clinical vision testing. Their cutting-edge technology allows for the tracking of subtle changes in sensory systems, which is crucial for diagnosing eye diseases and detecting changes in functional vision. Their flagship product, the Manifold®, utilizes the qCSF algorithm to provide precise assessments of vision on medical and mobile devices.

It has already proven to be effective in evaluating contrast sensitivity deficits in various eye conditions, including low vision, age-related macular degeneration, glaucoma, and more. With their advanced tools and innovative approach, AST aims to improve clinical evaluations of eye diseases, enable smaller and shorter clinical trials, and ultimately contribute to better health worldwide